STING1 and cancer: IFN-gamma released by activated CD8+ tumor-infiltrating lymphocytes activates the cell-intrinsic STING pathway in response to DNA damage in cancer, implicating an altered TME from activated CD8+ T cells that is measurable by the cancer (Xiong et al., 2022).